Richter expecting decline in revenue for 2014
Pharmaceutical producer Gedeon Richter expects a decline in revenue, calculated in euros, for 2014, CEO Erik Bogsch said on Wednesday, after the company published fourth-quarter earnings. Bogsch did not estimate the scale of the fall, but said exchange rate changes could affect the projection.
Richter projects stagnating revenue in Hungary and a similar outlook for new European Union member states. The company sees sales in Russia, its biggest export market, climbing as high as 5%, calculated in rubles. Sales in Ukraine are set to fall, while sales in other countries in the CIS region will rise 5% to 10%, calculated in US dollars.
Sales to the EU-28 are expected to climb 10% to 15%. US sales, calculated in dollars, are seen falling.
Richter expects Chinese sales to rise 12% to €40 million. In 2013, sales in this country accounted for 3% of the pharm’s total revenue.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.